high-risk patients. 3 Obesity (body mass index [BMI] >30 kg/m 2 ) exacerbates the problem of surgical-site infection after cesarean delivery. 4, 5 The impact of obesity has received particular attention, given the rising global levels of obesity. 6 Modern techniques for the prevention of wound complications include proper preoperative skin preparation, antiseptic surgical techniques, prophylactic antibiotics, and sterile postoperative dressings. 7 Despite these measures, wound complications after cesarean remain common.
More recently, prophylactic negativepressure wound therapy (NPWT) has emerged as a possible intervention for reducing surgical wound complications. This type of dressing, first approved by the Food and Drug Administration in 1995, uses negative pressure at the wound site to reduce edema, remove exudate, increase localized blood flow, stimulate granulation tissue growth, and ultimately accelerate wound healing. 8 Although most commonly utilized in the treatment of wounds, emerging research suggests that NPWT may be beneficial as prophylaxis among highrisk patients.
In 2010, 2 brands of modified, singleuse, battery-powered, portable NPWT devices (Prevena; KCI USA, San Antonio, TX, and PICO; Smith & Nephew, St Petersburg, FL) were Food and Drug Administration cleared for prophylactic application after wound closure at the time of surgery.
A recent meta-analysis of randomized controlled trials investigating the use of NPWT for closed surgical incisions showed significant reductions in wound infection, seroma formation, and wound exudate compared with a standard surgical dressing. 9 However, none of the included studies reported data for cesarean deliveries. While several observational studies and pilot randomized trials (RCTs) have supported the use of NPWT to reduce wound complications after cesarean delivery, the relatively small sample sizes in these studies limit their impact on clinical practice.
The objective of this systematic review and meta-analysis was to evaluate the effectiveness of prophylactic NPWT on the rate of surgical site infections and other wound complications in women undergoing cesarean delivery compared with standard surgical dressings.
Materials and Methods
This study did not involve any patient health information or human or animal experimentation and was therefore exempt from institutional review board review. Acelity played no role in the design, analysis, or interpretation of this study.
Search strategy and study selection
This systematic review and metaanalysis were conducted based on a predefined study protocol following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis criteria. 10 A medical librarian searched the published and gray literature for records discussing cesarean delivery and prophylactic NPWT in March 2017.
The librarian (L.S.) created search strategies using a combination of key words and controlled vocabulary in Ovid Medline 1946-, Embase 1947-, Scopus 1823-, Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials (CENTRAL), and Clinicaltrials.gov 1997-. If studies in Clinicaltrials.gov were reported as completed but did not provide results and a related publication was not found, the corresponding author was queried for unpublished results. The full search strategies can be found in the Appendix.
Two authors (R.K. and L.Y.) independently reviewed the search results to identify relevant studies. Titles and abstracts were screened, and articles deemed potentially relevant were retrieved for full-text review. Studies that did not involve NPWT and cesarean delivery in human subjects were excluded. Studies that investigated nonprophylactic use of NPWT or did not include outcome data relevant to wound infections or complications were also excluded. Reviews, commentaries, and case reports were also excluded.
Given that the use of prophylactic NPWT at cesarean delivery is still relatively novel, including only RCTs would likely be too restrictive and potentially introduce publication bias. Therefore, we included both RCTs and cohort studies. The bibliographies of included studies were searched for additional eligible studies. Lastly, an expert in the field (M.T.) was queried for any additional studies, which led to retrieval of a PhD thesis with interim results from an RCT.
Data extraction
Two reviewers (R.K. and L.Y.) independently reviewed eligible articles to extract data regarding study characteristics including design and location, inclusion and exclusion criteria, number of patients, patient demographics and comorbidities, frequency of wound complications, and hospital readmissions. The type of NPWT device and length of treatment in both the intervention and control groups was collected. In case of published abstracts, the first author was contacted for additional information regarding methods, baseline demographics, unpublished results, and detailed outcome information, although no additional results were obtained from this correspondence.
The 2 reviewers assessed the quality of each study based on criteria adapted from the Cochrane Handbook.
11 Individual study quality was assessed using predefined criteria. High-quality studies were defined as randomized trials with appropriate randomization method, clear definition of outcomes, and use of intention-to-treat analysis, while lowquality studies were missing 1 or more of these attributes. Outcomes were considered clearly defined if the authors provided an adequate level of detail about the criteria and timing of outcome data collection for this metric to be reproducible. Disagreements were resolved through arbitration and discussion with a third author (M.T.).
Outcomes
The primary outcome for this analysis was surgical-site infection after cesarean. This was chosen because of its clinical significance and the biological plausibility of NPWT on its prevention.
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Secondary outcomes included dehiscence, seroma, endometritis, a composite measure for wound complications, and hospital readmission. In studies for which there were both overall complication rates and rates stratified by complication type, the overall complication rate as reported was used for the outcome of wound complications to avoid counting patients multiple times.
Statistical Analysis
All statistical analyses were performed in the METAN add-on program in STATA version 14.2 (StataCorp LP, College Station, TX). Statistical heterogeneity was assessed using the Higgin's I 2 , with a value >30% considered to represent significant heterogeneity. 12 With the exception of a sensitivity analysis described in the following text, all risk estimates were reported as pooled relative risks with 95% confidence intervals (CI).
Additionally, we estimated pooled absolute risks for the primary outcome of surgical site infection in the NPWT and standard dressing groups using a meta-analysis of proportions and the associated absolute risk reduction and number needed to treat. A randomeffects model 13 was used for all meta-analyses, even when statistical heterogeneity was not evident, given the likelihood of clinical heterogeneity between studies. One study also reported adjusted odds ratios for surgical site infection and overall wound complications. 14 We conducted a sensitivity analysis to assess whether the use of the adjusted odds ratios would have an impact on the pooled estimates. Analyses were also stratified by study design, abstract vs full text, NPWT device type, and study quality to assess their impact on our estimates. All secondary analyses were prespecified. Publication bias was Flow diagram for study selection NPWT, negative-pressure wound therapy; RCT, randomized controlled trial.
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Results

Study selection
A total of 161 results were identified in the initial search and exported to EndNote. Following the removal of duplicates, a total of 107 unique citations remained. The titles and abstracts were screened for initial inclusion. Eighty-five studies were excluded for being additional duplicates (n ¼ 18), not related to the use of prophylactic NPWT after cesarean delivery (n ¼ 46), ineligible study designs (n ¼ 17), not reporting appropriate outcomes (n ¼ 3), and nonhuman subjects (n ¼ 1). Twenty-two remaining studies were reviewed in full text or published abstract if no full text was available. Of these, 16 studies were excluded for duplicate publication of results (n ¼ 2), not involving prophylactic NPWT alone (n ¼ 3), ineligible study designs (n ¼ 6), no usable results (n ¼ 3), and not having a valid comparison group (n ¼ 2) (Figure 1 ). One cohort study comparing prophylactic NPWT with standard dressing with regard to overall wound complications was not included because the authors reported odds ratios only and did not present the necessary count data for calculating absolute and relative risks. 17 In addition to the 6 remaining studies, 15,18-22 2 unpublished studies reported outcomes in ClinicalTrials. gov, 23, 24 one of which was published during manuscript preparation, 23 and one RCT was available as part of a published PhD thesis, 25 resulting in a total of 9 studies included in the analysis.
Study characteristics
Of the 9 studies meeting inclusion criteria, 6 studies were RCTs, while 3 were cohort studies (2 retrospective, 1 prospective with a historical control group 22 ). Six studies were full-text publications, 2 were published abstracts, and 1 was presented as results in ClinicalTrials.gov. Five studies were determined to be high quality and four were low quality. Seven studies were conducted in the United States and 2 were conducted in Australia 18 and Denmark. 25 Inclusion and exclusion criteria differed significantly across studies, with the majority including high-risk obese women above a given BMI threshold. Inclusion of scheduled or emergent cesarean deliveries in the studies was variable. Various prophylactic NPWT devices were used, with Prevena and PICO systems being the most common. Sample sizes ranged from 54 to 535 patients ( Table 1) .
Reporting of baseline characteristics varied across studies, with several studies lacking any information ( Table 2 ). The most commonly reported characteristics were age and BMI, while diabetes was the most commonly reported comorbidity. Only 2 studies reported race. While the age distribution appeared similar across studies, the average BMI was highly variable, ranging from 35 to 54 kg/m 2 in the intervention groups. Other potentially important comorbidities such as smoking history, parity, cesarean history, and chorioamnionitis were reported by 4 or fewer studies. Surgical characteristics including length of surgery and closure technique were infrequently reported.
Meta-analysis results and risk of bias
The absolute risk of developing surgical site infection was 5.0% (95% CI, 2.0e7.0%) with prophylactic NPWT and 11% (95% CI, 7.0e16.0%) with standard wound dressing. Compared with standard wound dressing, prophylactic NPWT was associated with a significantly lower risk of surgical-site infection (7 studies, pooled risk ratio (RR), 0.45, 95% CI, 0.31e0.66) ( Figure 2 and Table 3 ). The absolute risk reduction was e6.0 % (95% CI, e10.0 % to e3.0 %), with a number needed to treat of 17 (95% CI, 10e34).
There was no evidence of significant statistical heterogeneity (I 2 ¼ 9.9%). In stratified analyses the risk estimate suggested a lower rate of surgical site infection with the use of prophylactic NPWT across the type of estimates used, study design, NPWT device, reporting as full text or abstract, and study quality, although not statistically significant in some subgroups (Table 4 ). There was no evidence of publication bias (Egger test P ¼ .532) (Figure 3) .
Prophylactic NPWT was associated with a statistically significant reduction in composite wound complications (9 studies, pooled RR, 0.68, 95% CI, 0.49e0.94) but not in the other secondary outcomes, including dehiscence (5 studies, pooled RR, 0.86 95% CI, 0.61e1,23), seroma (2 studies, pooled RR, 1.21, 95% CI, 0.93e1.57), endometritis (3 studies, pooled RR, 0.37, 95% CI, 0.13e1.07), or hospital readmission (2 studies, pooled RR, 0.80, 95% CI, 0.23e2.76) ( Table 3) . 
Clinical implications
Our findings are consistent with previous studies showing a reduction in infection rates with the use of prophylactic NPWT after none obstetrical/gynecological surgical procedures. A meta-analysis of prophylactic NPWT after general surgical procedures found a significant reduction in surgical site infections. 9 In contrast to our study, the authors also reported a significant reduction in seroma. Cesarean deliveries were not included in that study. Another meta-analysis of ventral hernia repair including 5 retrospective cohort studies reported a reduction in surgical-site infection and wound dehiscence with the use of prophylactic NPWT but not in the rate of seroma. 26 A reduction in surgical-site infection with prophylactic NPWT is biologically plausible. Proposed mechanisms of prophylactic NPWT include wound shrinkage, induction of cellular stretch that promotes wound healing, removal of extracellular fluid, creation of a favorable environment for healing, and promotion of angiogenesis and neurogenesis. 27 It may also serve as a microbial barrier, increase blood flow, and improve tissue oxygenation. CD, cesarean delivery; CI, confidence interval; NPWT, negative-pressure wound therapy; RR, relative risk.
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Cellular deformation may also release cytokines and inflammatory factors that promote chemotaxis of other cells, including leukocytes, into the area. 8, 28 Of our secondary outcomes, only overall wound complications were significantly reduced with prophylactic NPWT. The inclusion of surgical-site infection in the composite wound complication measure likely explains this result in the absence of other significant differences in dehiscence, seroma, endometritis, and hospital readmission. However, these secondary outcomes were reported by only a subset of studies and thus may be limited by small overall sample sizes.
Additionally, composite wound complication measures are difficult to interpret because of a lack of consistent definitions across studies. Nevertheless, these results are encouraging with regard to the potential ability of prophylactic NPWT to alter patient outcomes postoperatively.
Strengths and Weaknesses
Strengths of this review include the predesigned protocol, comprehensive search strategy involving an expert librarian (L.S.), 2 investigators independently screening all articles for eligibility, Stratified analysis of the effect of prophylactic NPWT on surgical-site infection, composite wound complications, and wound dehiscence 
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and extracting data to reduce bias. We used a random-effects model to pool data to take into account heterogeneity between studies, even in the absence of demonstrable statistical heterogeneity. We included published abstracts to avoid publication bias because full-text articles represented only a proportion of studies. Finally, we conducted sensitivity and stratified analyses to assess the impact of various factors on our findings. There are limitations that should be considered. Our findings carry forward the limitations of the primary studies. The relatively small number of studies and significant variability in outcome reporting are important limitations. While the inclusion of published abstracts and unpublished studies reduced publication bias, it carries the risk of including lower quality nonepeerreviewed data. Moreover, there was significant heterogeneity between the studies included.
The inclusion of cohort studies carries a risk of confounding, especially because many potential confounders were not consistently assessed in the primary studies. However, the sensitivity analysis including adjusted estimates produced similar findings, suggesting robustness of our findings. Definitions of surgicalsite infections and other wound complication were unclear in some studies. 14, 21 Side effects were not consistently reported in the studies and could not be synthesized. This is important because some studies have reported high rates of side effects including skin blisters, erythema, and wound bleeding with the use of prophylactic NPWT after other types of surgical procedures. 29 Finally, we did not include a costeffectiveness analysis as part of the current study. Given that prophylactic NPWT devices cost between $200 and $500 USD, this is an important consideration in applying these results in a clinical setting. 30 Since 2015, 3 cost-effectiveness analyses of prophylactic NPWT for poste cesarean delivery have been performed using various methods but with inconclusive results. [30] [31] [32] Two studies based in Australia suggested that prophylactic NPWT was cost effective in obese women undergoing cesarean delivery, although the degree of uncertainty around these estimates was high. 31, 32 A US-based decision-analytic model favored the standard postoperative dressing as the most cost-effective strategy in a patient population with a surgical-site infection rate of 14% or less. 30 On the other hand, prophylactic NPWT was potentially cost effective in populations with a higher risk of surgical-site infection. Based on this model and our pooled estimates of absolute risk, it would seem that prophylactic NPWT would not be cost effective in the patient population represented in our meta-analysis. However, as previously noted, patient characteristics were heterogeneous between studies and may not truly reflect a high-risk population as defined in these cost-effectiveness analyses.
Clinical heterogeneity may also explain why the conclusions differed between the Australian analyses predicated on a specific group of women and the US-based model that potentially involved a broader population of interest. Nevertheless, several additional studies, including those in our sample, have been conducted since the publication of these cost-effectiveness analyses, necessitating an updated assessment to incorporate these findings as well as changes in device pricing over time.
Summary and future research direction
In conclusion, the results of this metaanalysis suggest that use of prophylactic NPWT after cesarean delivery in highrisk patients is associated with a significant reduction in the risk of surgical site infection. However, because of the limited number and clinical heterogeneity between studies, further research is needed. Results of ongoing clinical trials 33, 34 powered to assess effectiveness, side effects and cost-effectiveness will ajog.org Systematic Reviews
